成人先天性心脏病心衰合并心律失常的管理:JACC前沿综述
本综述聚焦成人先天性心脏病(ACHD)中心力衰竭与心律失常的共存问题,指出二者是该人群发病和死亡的最重要心血管原因,且机制、治疗和预后相互重叠。文章按先天性心脏病典型亚型拆分,探讨病理生理、评估和治疗策略的细微差异,推荐平行且互动的多学科管理方法。
要点
- 心衰和心律失常在ACHD中近乎普遍共存,需识别二者交互作用。
- 按先心病亚型细化病理生理、评估和治疗策略。
- 推荐多学科平行互动的临床管理模式。
核心结论
- 心衰与心律失常是ACHD最重要的心血管发病和死亡原因,二者机制、治疗和预后重叠,需增强认识并采取多学科互动管理。
研究设计与样本
- 本文为JACC前沿综述,按先天性心脏病典型亚型拆分,探讨心衰合并心律失常的病理生理、评估和治疗。
主要发现
- 心衰和心律失常在ACHD中近乎普遍共存,其重叠在心脏病学中尤为常见。
- 二者传统上被视为独立临床领域,但常在同一患者中并存并相互影响。
临床怎么用
- 临床管理ACHD时需高度关注心衰与心律失常的交互作用,并合理运用可用的药物和介入资源。
- 推荐采用平行且互动的多学科方法进行临床管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Together, heart failure and arrhythmia represent the most important cardiovascular sources of morbidity and mortality among adults with congenital heart disease (ACHDs). Although traditionally conceptualized as operating within 2 distinct clinical silos, these scenarios frequently coexist within the same individual; consequently the mechanistic, therapeutic, and prognostic overlap between them demands increased recognition. In fact, given the near ubiquity of heart failure and arrhythmia among ACHDs, there is perhaps no other arena within cardiology where this critical intersection is more frequently observed. Optimal care for ACHDs therefore requires a heightened awareness of the relevant interactions as well as the pharmacologic and interventional resources that are increasingly available to the treating cardiologist. This review explores and highlights the overlap between these 2 fields to recommend a parallel, yet interactive, multidisciplinary approach to clinical management. Congenital heart disease categories are broken down into their archetypal subtypes to highlight subtleties of the pathophysiology, evaluation, and therapeutic approach.
引用
- Moore JP, Marelli A, Burchill LJ, et al. Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 36456053. doi:10.1016/j.jacc.2022.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。